Indalo Therapeutics develops novel integrin antagonists therapies for the treatment of fibrotic diseases.
Business Model:
Revenue: $5M
Employees: 11-50
Address: 400 Technology Square
City: Cambridge
State: MA
Zip: 02139
Country: US
Indalo Therapeutics develops novel integrin antagonists therapies for the treatment of fibrotic diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2013 | Seed Round | 1 | - |
BioGenerator BioGenerator |
6/2017 | Equity | $9M |
BioGenerator Missouri Technology Corporation iSelect Fund |
8/2017 | Venture Round | 4 | $9M |
Argonautic Ventures Atlas Venture Cultivation Capital F-Prime Capital Argonautic Ventures Atlas Venture Cultivation Capital F-Prime Capital |
9/2015 | Equity | $100k | 10/2015 | Seed Round | $800k | 12/2014 | Equity | $595.6k | 4/2013 | Seed Round | 1 | - |
BioGenerator BioGenerator |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|